glutathione and triple negative breast cancer Ratiometrically designed nanoprodrug for triple-negative treatment Excessive glutathione intake contributes to
Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis PMC NRF2 activation by cysteine as a survival mechanism for triple negative breast cancer cells Oncogene Full article: Glutathione and acid dual responsive nanomaterials loaded with methotrexate and magnolol for triple negative breast cancer treatment Targeting the redox programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance Cell Death Discovery
Pay in 4 interest-free payments of $7.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 17 - Sep 22



